The Cannigma to Be Featured on Ted Danson’s CNBC Show

The Cannigma to Be Featured on Ted Danson’s CNBC Show

Press Release (ePRNews.com) - HERZLIYA, Israel - Apr 21, 2021 - CNBC’s “Advancements With Ted Danson” is scheduled to run a special feature on science-based cannabis publisher The Cannigma in its upcoming episode this Saturday, April 24.

Featuring Cannigma CEO Elana Goldberg, cannabis researcher and pediatrician Dr. Orit Stolar, and Perry Davidson, CEO of medical vaporizer company Syke, the segment explains why progress in the field of cannabis is dependent upon educating the broader public about the plant.

“Education is going to be crucial when it comes to the cannabis industry expanding,” explains Goldberg in the episode. “If lawmakers properly understand what we now know from cannabis research about the plant, they are going to be able to make the right laws which are going to help cannabis businesses really thrive.”

Once that type of regulatory transformation takes place, Goldberg continues, “researchers are going to be able to look into the myriad uses for the plant, healthcare providers will have all of the information they need to treat their patients well.”

The tools being developed by The Cannigma are an important pillar of that massive undertaking of educating the world about cannabis and allowing anyone to make decisions for themselves about the plant — based on reliable scientific research.

After airing on CNBC, the episode will be available for streaming on Amazon Prime.

The Cannigma is a cannabis content platform that creates and distributes cannabis information, products and services while maintaining an unbiased scientific approach.

For more information, visit https://www.cannigma.com

Press Contact:
info@cannigma.com

Source : The Cannigma
SHARE :  

You may also like this  

CATEGORIES : Cannabis

Login

Or using ePRNews Account

Don't have an account ? Sign Up

Register New Account

Already have an account ? Login

Reset Password

Already have an account ? Login

DISCLAIMER

If you have any concerns regarding this press release, please contact the Author / Media Contact / Business of this press release. ePRNews is not resposible for the accuracy of the news posted and do not endorse, support any product/ services/ business mentioned and hereby disclaims any content contained in this press release.